McKesson Corporation (MCK) : Fridays money flow points at investors jumping to buy the stock on the weakness of price. $4.08 million worth of transactions were on upticks, whereas, the downticks accounted for $1.43 million worth of transactions. The net money flow was a positive $2.65 million and the uptick to downtick ratio was 2.86. The net money flow into the stock was $2.69 million. The lack of interest in trading on downticks shows that the investors dont want to sell their holdings. The upticks accounted for $2.69 million of the total block trades, indicating continued buying interest on weakness, which bodes well for the future of the stock. McKesson Corporation (MCK) was trading at $196.39, down $0.11 during day. The stock slid -0.06% over the previous days close. For the week, the stock recorded -0.38% over the previous weeks close.
McKesson Corporation (MCK) has been rated by 10 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $220 and the lowest price target forecast is $172. The average forecast of all the analysts is $193.3 and the expected standard deviation is $16.55.
McKesson Corporation (NYSE:MCK): stock turned positive on Friday. Though the stock opened at $196.78, the bulls momentum made the stock top out at $196.96 level for the day. The stock recorded a low of $195.8201 and closed the trading day at $196.57, in the green by 0.04%. The total traded volume for the day was 869,619. The stock had closed at $196.5 in the previous days trading.
In a related news, The officer (EVP & Chief Financial Officer), of Mckesson Corp, Beer James A had unloaded 5,500 shares at $199 per share in a transaction on July 14, 2016. The total value of transaction was $1,094,500. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.